About K Health
K Health is a private company based in New York, New York. It has reported $412,375,927 raised in ten offerings on Form D since November 2016. Its chief executive is Adam Singolda.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Aug 19, 2026 | $58,949,942of $68.9M target | 19 | $3.1M | EquityRule 506(b) | Form D ↗ |
| Jul 15, 2024 | Jul 24, 2024 | $88,356,397of $134.1M target | 26 | $3.3M | EquityRule 506(b) | Form D ↗ |
| Jan 4, 2021 | Jan 19, 2021 | $132,026,528fully sold | 16 | $8.2M | EquityRule 506(b) | Form D ↗ |
| Aug 27, 2020 | Nov 19, 2020 | $36,656,162fully sold | 9 | $4.0M | EquityRule 506(b) | Form D ↗ |
| Feb 19, 2020 | Mar 5, 2020 | $47,920,741of $50.0M target | 21 | $2.2M | EquityRule 506(b) | Form D ↗ |
| Jul 2, 2019 | Jul 23, 2019 | $11,999,999target not set | 1 | $11.9M | EquityRule 506(b) | Form D ↗ |
| Dec 6, 2018 | Dec 19, 2018 | $24,999,970fully sold | 15 | $1.6M | EquityRule 506(b) | Form D ↗ |
| Jan 17, 2018 | Jan 30, 2018 | $5,121,188of $5.5M target | 10 | $512K | EquityRule 506(b) | Form D ↗ |
| Jun 1, 2017 | Jun 13, 2017 | $3,200,000fully sold | 7 | $457K | EquityRule 506(b) | Form D ↗ |
| Nov 4, 2016 | Nov 21, 2016 | $3,145,000of $3.3M target | 11 | $285K | EquityRule 506(b) | Form D ↗ |
| Total, ten offerings | $412,375,927 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on K Health's Form D filed Aug 19, 2026.
Niyum Gandhi
CFO & Treasurer, Mass General Brigham, director
Vivek Pattipati
Partner, Valor Equity Partners and director
C. Okey Agba
EVP & CFO, Hartford HealthCare, director
NZ
Nir Zohar
Director
ZS
Zac Siegel
Executive officer
Saad Ehtisham
President & CEO, Atlantic Health, director
AZ
Alejandro Zubillaga
Director
Earlier filings also listed Hans Tung (director, last listed Jul 2024), Ashok Balakrishnan (executive officer, last listed Jul 2024) and Antonio Gracias (director, last listed Jul 2024).
Sources
- SECK Health, Inc. filing history
- CompanyOur Team
- CompanyPrivacy Policy